Exchange: NYSEArca·Updated 01:52 AM EDT
NVOX logo

NVOXDefiance Daily Target 2X Long NVO ETF

$15.53
$0.25
(1.58%)
Overnight
Prev Close $15.78
Vol474,186.00
52W High$54.76
52W Low$9.23
News
all
press releases
News Placeholder
FDA Clears Popular Weight-Loss Drugs Of Suicide Risk After Review Of Over 100K Patients, Asks Drugmakers To Remove Warnings
The request applies to GLP-1 RAs approved for obesity, including Novo Nordisk’s Wegovy and Saxenda and Eli Lilly’s Zepbound.
Stocktwits
<
...
1
>

Advertisement|Remove ads.